Literature DB >> 21478891

Can an iPS cell secure its genomic fidelity?

R Sarig, V Rotter.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21478891      PMCID： PMC3131921          DOI： 10.1038/cdd.2011.14

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  11 in total

1.  Identification and classification of chromosomal aberrations in human induced pluripotent stem cells.

Authors:  Yoav Mayshar; Uri Ben-David; Neta Lavon; Juan-Carlos Biancotti; Benjamin Yakir; Amander T Clark; Kathrin Plath; William E Lowry; Nissim Benvenisty
Journal:  Cell Stem Cell       Date:  2010-10-08       Impact factor: 24.633

Review 2.  Protecting genomic integrity in somatic cells and embryonic stem cells.

Authors:  Y Hong; R B Cervantes; E Tichy; J A Tischfield; P J Stambrook
Journal:  Mutat Res       Date:  2006-08-17       Impact factor: 2.433

Review 3.  DNA repair in murine embryonic stem cells and differentiated cells.

Authors:  Elisia D Tichy; Peter J Stambrook
Journal:  Exp Cell Res       Date:  2008-02-26       Impact factor: 3.905

4.  Genomic instability in induced stem cells.

Authors:  C E Pasi; A Dereli-Öz; S Negrini; M Friedli; G Fragola; A Lombardo; G Van Houwe; L Naldini; S Casola; G Testa; D Trono; P G Pelicci; T D Halazonetis
Journal:  Cell Death Differ       Date:  2011-02-11       Impact factor: 15.828

5.  Preservation of genomic integrity in mouse embryonic stem cells.

Authors:  Peter J Stambrook; Elisia D Tichy
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 6.  The first 30 years of p53: growing ever more complex.

Authors:  Arnold J Levine; Moshe Oren
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

7.  DNA damage responses in human induced pluripotent stem cells and embryonic stem cells.

Authors:  Olga Momcilovic; Leah Knobloch; Jamie Fornsaglio; Sandra Varum; Charles Easley; Gerald Schatten
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

8.  Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells.

Authors:  Rachel Sarig; Noa Rivlin; Ran Brosh; Chamutal Bornstein; Iris Kamer; Osnat Ezra; Alina Molchadsky; Naomi Goldfinger; Ori Brenner; Varda Rotter
Journal:  J Exp Med       Date:  2010-08-09       Impact factor: 14.307

9.  Stem cells: The promises and perils of p53.

Authors:  Valery Krizhanovsky; Scott W Lowe
Journal:  Nature       Date:  2009-08-27       Impact factor: 49.962

10.  Adaptation to culture of human embryonic stem cells and oncogenesis in vivo.

Authors:  Duncan E C Baker; Neil J Harrison; Edna Maltby; Kath Smith; Harry D Moore; Pamela J Shaw; Paul R Heath; Hazel Holden; Peter W Andrews
Journal:  Nat Biotechnol       Date:  2007-02       Impact factor: 54.908
View more
  2 in total

Review 1.  Embryonic stem cells and inducible pluripotent stem cells: two faces of the same coin?

Authors:  Francesco Romeo; Francesco Costanzo; Massimiliano Agostini
Journal:  Aging (Albany NY)       Date:  2012-12       Impact factor: 5.682

2.  Lower genomic stability of induced pluripotent stem cells reflects increased non-homologous end joining.

Authors:  Minjie Zhang; Liu Wang; Ke An; Jun Cai; Guochao Li; Caiyun Yang; Huixian Liu; Fengxia Du; Xiao Han; Zilong Zhang; Zitong Zhao; Duanqing Pei; Yuan Long; Xin Xie; Qi Zhou; Yingli Sun
Journal:  Cancer Commun (Lond)       Date:  2018-07-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.